SCHEMBL18101201

SCHEMBL18101201

C/C(=C\CCl)CCCC(C)(C)[Si](O)(c1ccccc1)c1ccccc1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18012101 1.00 MAPT (0.31) MAPT
SCHEMBL18012102 0.87 PTPN1 (0.33) MAPT
SCHEMBL16615709 0.87 PTPN1 (0.33) MAPT
SCHEMBL18101204 0.83 PTPN1 (0.32) MAPT
SCHEMBL12640536 0.77 PTGS2 (0.38)
SCHEMBL16615681 0.76 TSHR (0.33) MAPT
SCHEMBL15121071 0.76 HDAC3 (0.42) MAPT
SCHEMBL10000059 0.75 ALOX15 (0.46) MAPT
SCHEMBL16137785 0.75
SCHEMBL10000060 0.74 HPGD (0.40) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016187788-A1 FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL FOR TREATING HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2016-12-01 WO disclosed
WO-2016191239-A1 FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL FOR TREATING HIV INFECTION MERCK SHARP & DOHME CORP. (US) 2016-12-01 WO disclosed
WO-2016154527-A1 PHOSPHATE-SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2016-09-29 WO disclosed